Skip to the page

Data / Form D filings / Accure Acne, Inc.

Accure Acne, Inc.: Form D filings

Accure Acne, Inc., a health care company in Boulder, CO, filed 7 Form D notices with the SEC between 2017 and 2025. The latest, on November 25, 2025, reports $21.8 million sold of a $24 million offering to 106 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4699 Nautilus Ct South, Suite 205, Boulder, CO, 80301
Phone
(720) 615-3570
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1698865

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 25, 2025Amendment$24,000,000$21,782,114$2,217,886106Jan 26, 2023sec.gov
Feb 8, 2024Amendment$24,000,000$21,211,195$2,788,80589Jan 26, 2023sec.gov
Feb 8, 2023New notice$20,000,000$7,951,197$12,048,80320Jan 26, 2023sec.gov
Apr 19, 2022New notice$5,000,000$3,500,000$1,500,00012Apr 4, 2022sec.gov
Oct 8, 2021New notice$20,000,000$2,011,000$17,989,00020Sep 29, 2021sec.gov
May 30, 2017Amendment$2,225,000$2,225,00013Feb 22, 2017sec.gov
Mar 8, 2017New notice$2,000,000$400,000$1,600,0003Feb 22, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Samuel E. NavarroDirector
Karl NichollsExecutive Officer
Jeffrey E. O'Donnell, Sr.Director
Christopher CarltonExecutive Officer, Director
Edward BarberaDirector

Other health care companies in Colorado that filed recently

Every Form D from the week of Nov 24, 2025 · All recent filings in Colorado · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Accure Acne, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.